Literature DB >> 23618864

MicroRNA-101 suppresses motility of bladder cancer cells by targeting c-Met.

Zhenghui Hu1, Yiwei Lin, Hong Chen, Yeqing Mao, Jian Wu, Yi Zhu, Xin Xu, Xianglai Xu, Shiqi Li, Xiangyi Zheng, Liping Xie.   

Abstract

MicroRNAs (miRNAs) are small non-coding RNAs that play regulatory roles by repressing translation or cleaving RNA transcripts. Here, we report that the expression of microRNA-101 (miR-101) is down-regulated in human bladder cancer tissue versus normal adjacent tissue. To better characterize the role of miR-101 in bladder cancer, we conducted a gain-of-function analysis by transfecting the bladder cancer cell line T24 with chemically synthesized miR-101 mimics. We found that miR-101 directly targets c-Met via its 3'-UTR. Specifically, forced expression of miR-101 decreased c-Met expression at both mRNA and protein levels, consequently inhibiting T24 cell migration and invasion in a c-Met-dependent manner. In conclusion, we have shown miR-101 to be a novel suppressor of T24 cell migration and invasion through its negative regulation of c-Met.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23618864     DOI: 10.1016/j.bbrc.2013.04.042

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  32 in total

1.  Down-regulation of Long Noncoding RNA MALAT1 Protects Hippocampal Neurons Against Excessive Autophagy and Apoptosis via the PI3K/Akt Signaling Pathway in Rats with Epilepsy.

Authors:  Qiang Wu; Xuewei Yi
Journal:  J Mol Neurosci       Date:  2018-06-01       Impact factor: 3.444

2.  miR-101 suppresses tumor proliferation and migration, and induces apoptosis by targeting EZH2 in esophageal cancer cells.

Authors:  Chen Lin; Fei Huang; Qiao-Zhi Li; Ya-Jing Zhang
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

3.  MIR-300 in the imprinted DLK1-DIO3 domain suppresses the migration of bladder cancer by regulating the SP1/MMP9 pathway.

Authors:  Huaqing Yan; Jiangfeng Li; Yufan Ying; Haiyun Xie; Hong Chen; Xin Xu; Xiangyi Zheng
Journal:  Cell Cycle       Date:  2018-12-18       Impact factor: 4.534

4.  miR-613 inhibits bladder cancer proliferation and migration through targeting SphK1.

Authors:  Haifeng Yu; Ping Duan; Haibo Zhu; Dapang Rao
Journal:  Am J Transl Res       Date:  2017-03-15       Impact factor: 4.060

Review 5.  Dysregulation of the Met pathway in non-small cell lung cancer: implications for drug targeting and resistance.

Authors:  Joseph J Sacco; Michael J Clague
Journal:  Transl Lung Cancer Res       Date:  2015-06

6.  Effect of microRNA-101 on proliferation and apoptosis of human osteosarcoma cells by targeting mTOR.

Authors:  Song Lin; Nan-Nan Shao; Lei Fan; Xiu-Cai Ma; Fei-Fei Pu; Zeng-Wu Shao
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-12-06

7.  MicroRNA-101 polymorphisms and risk of head and neck squamous cell carcinoma in a Chinese population.

Authors:  Limin Miao; Lihua Wang; Hua Yuan; Dong Hang; Longbiao Zhu; Jiangbo Du; Xun Zhu; Bing Li; Ruixia Wang; Hongxia Ma; Ning Chen
Journal:  Tumour Biol       Date:  2015-10-22

8.  miR-665 inhibits epithelial-to-mesenchymal transition in bladder cancer via the SMAD3/SNAIL axis.

Authors:  Weiyu Wang; Yufan Ying; Haiyun Xie; Jiangfeng Li; Xueyou Ma; Liujia He; Mingjie Xu; Shiming Chen; Haixiang Shen; Xiangyi Zheng; Ben Liu; Xiao Wang; Liping Xie
Journal:  Cell Cycle       Date:  2021-07-01       Impact factor: 5.173

9.  MicroRNA-101 is repressed by EZH2 and its restoration inhibits tumorigenic features in embryonal rhabdomyosarcoma.

Authors:  Roberta Ciarapica; Rossella Rota; Serena Vella; Silvia Pomella; Pier Paolo Leoncini; Marta Colletti; Beatrice Conti; Victor E Marquez; Antonio Strillacci; Josep Roma; Soledad Gallego; Giuseppe M Milano; Maurizio C Capogrossi; Alice Bertaina
Journal:  Clin Epigenetics       Date:  2015-08-06       Impact factor: 6.551

10.  MicroRNA-101 is a potential prognostic indicator of laryngeal squamous cell carcinoma and modulates CDK8.

Authors:  MingHua Li; LinLi Tian; Hui Ren; XiaoXue Chen; Yu Wang; JingChun Ge; ShuLiang Wu; YaNan Sun; Ming Liu; Hui Xiao
Journal:  J Transl Med       Date:  2015-08-19       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.